These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 22234810)
1. A comparison of case-finding strategies in the UK for the management of hip fractures. Johansson H; Kanis JA; Oden A; Compston J; McCloskey E Osteoporos Int; 2012 Mar; 23(3):907-15. PubMed ID: 22234810 [TBL] [Abstract][Full Text] [Related]
2. FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK. McCloskey E; Kanis JA; Johansson H; Harvey N; Odén A; Cooper A; Cooper C; Francis RM; Reid DM; Marsh D; Selby P; Thompson F; Hewitt S; Compston J Osteoporos Int; 2015 Aug; 26(8):2091-9. PubMed ID: 26077380 [TBL] [Abstract][Full Text] [Related]
3. A comparative study between the implementation of the FRIDEX calibration and the NOGG guideline in the management of osteoporosis in routine clinical practice. Kyriakos G; Vidal-Casariego A; Quiles-Sánchez LV; Calleja-Fernández A; Ávila-Turcios D; Urosa-Maggi JA; Ballesteros-Pomar MD; Cano-Rodríguez I Reumatol Clin; 2017; 13(5):258-263. PubMed ID: 27373582 [TBL] [Abstract][Full Text] [Related]
4. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A; Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937 [TBL] [Abstract][Full Text] [Related]
5. BMD, clinical risk factors and their combination for hip fracture prevention. Johansson H; Kanis JA; Oden A; Johnell O; McCloskey E Osteoporos Int; 2009 Oct; 20(10):1675-82. PubMed ID: 19291344 [TBL] [Abstract][Full Text] [Related]
6. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study. Leslie WD; Martineau P; Bryanton M; Lix LM Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351 [TBL] [Abstract][Full Text] [Related]
7. FRAX® based intervention thresholds for management of osteoporosis in Singaporean women. Chandran M; McCloskey EV; Thu WPP; Logan S; Hao Y; Tay D; Ang WC; Aung TKK; Choo KS; Ali A; Yan SX; Huang XF; Liu XM; Yong EL; Lekamwasam S Arch Osteoporos; 2018 Nov; 13(1):130. PubMed ID: 30456726 [TBL] [Abstract][Full Text] [Related]
8. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Kanis JA; McCloskey EV; Johansson H; Cooper C; Rizzoli R; Reginster JY; Osteoporos Int; 2013 Jan; 24(1):23-57. PubMed ID: 23079689 [TBL] [Abstract][Full Text] [Related]
9. Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity. McCloskey EV; Johansson H; Harvey NC; Compston J; Kanis JA Osteoporos Int; 2017 Jan; 28(1):71-76. PubMed ID: 27438128 [TBL] [Abstract][Full Text] [Related]
10. Health-economic comparison of three recommended drugs for the treatment of osteoporosis. Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171 [TBL] [Abstract][Full Text] [Related]
11. Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis. Ström O; Jönsson B; Kanis JA Osteoporos Int; 2013 Apr; 24(4):1491-502. PubMed ID: 23224141 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of applying the NOF, NOGG and Taiwanese guidelines to a cohort of Chinese early postmenopausal women. Cheung E; Kung AW; Tan KC Clin Endocrinol (Oxf); 2014 Feb; 80(2):200-7. PubMed ID: 24010883 [TBL] [Abstract][Full Text] [Related]
13. Performance of the Brazilian Fracture Assessment Risk Tool (FRAX) model and the age-dependent intervention thresholds according to National Osteoporosis Guideline Group (NOGG) guidelines on fracture prediction in community-dwelling older adults: the São Paulo Ageing and Health (SPAH) Study. Freitas TQ; Olalla LFG; Machado LG; Figueiredo CP; Takayama L; de Falco Caparbo V; Domiciano DS; Pereira RMR Arch Osteoporos; 2024 Jul; 19(1):59. PubMed ID: 38990403 [TBL] [Abstract][Full Text] [Related]
14. Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability. McCloskey EV; Fitzpatrick LA; Hu MY; Williams G; Kanis JA Arch Osteoporos; 2019 Feb; 14(1):15. PubMed ID: 30719589 [TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan. Moriwaki K; Noto S Osteoporos Int; 2017 Feb; 28(2):621-632. PubMed ID: 27699441 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the 10-year risk of fracture in Italian postmenopausal women using FRAX®: a north Italian multicenter study. Pedrazzoni M; Girasole G; Giusti A; Barone A; Pioli G; Passeri G; Palummeri E; Bianchi G J Endocrinol Invest; 2011 Dec; 34(11):e386-91. PubMed ID: 21750394 [TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of the Screening for the Primary Prevention of Fragility Hip Fracture in Spain Using FRAX Martin-Sanchez M; Comas M; Posso M; Louro J; Domingo L; Tebé C; Castells X; Espallargues M Calcif Tissue Int; 2019 Sep; 105(3):263-270. PubMed ID: 31172231 [TBL] [Abstract][Full Text] [Related]
18. Impact of population-based or targeted BMD interventions on fracture incidence. Harvey NC; Kanis JA; Liu E; Vandenput L; Lorentzon M; Cooper C; McCloskey E; Johansson H Osteoporos Int; 2021 Oct; 32(10):1973-1979. PubMed ID: 33758991 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong. Su Y; Lai FTT; Yip BHK; Leung JCS; Kwok TCY Osteoporos Int; 2018 Aug; 29(8):1793-1805. PubMed ID: 29774400 [TBL] [Abstract][Full Text] [Related]
20. Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study. Yang S; Leslie WD; Luo Y; Goertzen AL; Ahmed S; Ward LM; Delubac I; Lix LM Osteoporos Int; 2018 Jan; 29(1):191-200. PubMed ID: 29038836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]